Belgium· BE-AMP-SAM507733-00

Idarubicin Accord 10 mg/10 ml

A idarubicin product containing idarubicin hydrochloride, registered in Belgium by Accord Healthcare. The same ATC class is registered in 17 of our 19 countries.

ATC L01DB06

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about idarubicin hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Idarubicin is registered in 17 of 19 countries.

Countries holding a registration under ATC L01DB06 (idarubicin), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search idarubicin products by name

Idarubicin · ATC L01DB06

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Idarubicin Hydrochloride
Manufacturer: Accord Healthcare
Country: Belgium (BE)
ATC code: L01DB06
ATC class: Idarubicin
Defined daily dose: 6 mg, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

435 interactions on record for idarubicin.

Graded by severity as the source publishes them — 98 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check idarubicin against other medicines How interaction checks work

Idarubicin · interactions on record

435 records

98 severe
328 moderate
9 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
QuinidineC01BA01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Idarubicin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All idarubicin products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Idarubicin Ebewe, Idarubicin Hexal
Bulgaria · Заведос
Cyprus · Zavedos
Czechia · Zavedos
Germany · Idarubicin Hexal, Idarubicin Hikma
Denmark · Zavedos
Spain · Idarubicina Sandoz, Zavedos
Finland · Idarubicin Accord, Zavedos
France · Idarubicine Accord, Zavedos
United Kingdom (Northern Ireland) · Idarubicin Accord Healthcare, Idarubicin Sandoz
Greece · Zacorist, Zavedos
Croatia · Zavedos
Hungary · Zavedos
Ireland · Zavedos
Iceland · Zavedos
Italy · Zavedos
Lithuania · Zavedos
Luxembourg · Zavedos
Latvia · Zavedos
Netherlands · Zavedos
Norway · Zavedos
Poland · Idarubicin Accord, Zavedos
Portugal · Idarrubicina Accord, Idarrubicina Azevedos
Romania · Zavedos
Sweden · Zavedos
Slovenia · Zavedos
Slovakia · Zavedos

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/416bb22b-d045-4006-a181-8537d116d1e5
GET /v1/drugs/416bb22b-d045-4006-a181-8537d116d1e5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Idarubicin Accord 10 mg/10 ml",
  "name_fr": "Idarubicin Accord 10 mg/10 ml",
  "name_nl": "Idarubicin Accord 10 mg/10 ml",
  "amp_code": "SAM507733-00",
  "strengths": [
    "1.0000",
    "1.0000",
    "25.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Idarubicin Hydrochloride",
    "Glycerol",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Idarubicin",
  "authorisation_numbers": [
    "BE507733"
  ]
}

API reference MCP server Plans

See everything about idarubicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console